ClinicalTrials.Veeva

Menu

Neuropsychological Indicators of SCD Progression (SCD-CI)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Biomarkers
Neurodegenerative Diseases
Cognitive Decline
Cognitive Assessment
Subjective Cognitive Decline
Neurocognitive Disorders

Study type

Observational

Funder types

Other

Identifiers

NCT04880252
PI2019_843_0039

Details and patient eligibility

About

Some patients with subjective cognitive decline (SCD) progress to neurocognitive disorders (NCD), whereas others remain stable; however, the neuropsychological determinants of this progression have not been identified. The investigators objective was to examine baseline neuropsychological indicators that could discriminate between people in whom the SCD progressed to a mild or major NCD and people in whom the SCD remained stable.

The investigators retrospectively included patients consulting for SCD at a university medical center's memory center (Amiens, France) and who had undergone three or more neuropsychological assessments at least 6 months apart. The relationship between domain-specific scores and the global cognitive score (GCS, as a function of final status (stable SCD vs. progression toward a mild or major NCD)) was examined using a generalized linear mixed model.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who had been referred to the memory center at Amiens University Medical Center (Amiens, France).
  • patients who had undergone three neuropsychological assessments at least 6 months apart, from 2005
  • patients who met the criteria for SCD.

Exclusion criteria

  • patients who didn't meet the criteria for SCD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems